Subsidies

conoce_transparencia_titulo

PORTAL FOR TRANSPARENCY

conoce_transparencia_info-institucional_subvenciones-titulo

Subsidies

Transparencia Portlet

subsidy
A result has not been found with the information entered.
Title Code of transcript Funder Beneficiary Entity Call for applications Date of award Amount Awarded Other Funds
Characterization of hemostatic alterations in patients receiving CAR-T cell therapy and their relationship with thrombotic and hemorrhagic complications. development of thrombotic and hemorrhagic complications. PI23/00890 HIGH SCHOOL CARLOS III HEALTH CENTRE high school of research Sanitaria de Navarra - IdiSNA 2023 AES Projects research 18-12-2023 90.000,00€ ERDF funds
Role of the MMP14/GDF15 axis in obesity-related metabolic alterations and their interaction with age. PI23/00208 HIGH SCHOOL CARLOS III HEALTH CENTRE high school of research Sanitaria de Navarra - IdiSNA 2023 AES Projects research 18-12-2023 177.500,00€ ERDF funds
IDENTIFICATION OF TRANSCRIPTIONAL MECHANISMS OF PROGRESSION AND RESISTANCE TO TREATMENT IN PATIENTS WITH HIGH-RISK MYELODYSPLASTIC PATIENTS WITH HIGH RISK MYELODYSPLASTIC SYNDROMES PI23/00516 HIGH SCHOOL CARLOS III HEALTH CENTRE high school of research Sanitaria de Navarra - IdiSNA 2023 AES Projects research 18-12-2023 228.750,00€ ERDF funds
Characterization of Chronic Spontaneous Urticaria Based on Response to Antihistamines: Approach to Intracellular Signaling Molecules. PI23/01280 HIGH SCHOOL CARLOS III HEALTH CENTRE high school of research Sanitaria de Navarra - IdiSNA 2023 AES Projects research 18-12-2023 215.000,00€ ERDF funds
DSTYK inhibition as the basis for a novel targeted therapy to break resistance to standard treatments in lung cancer PI23/00223 HIGH SCHOOL CARLOS III HEALTH CENTRE FIMA 2023 AES Projects research 18-12-2023 177.500,00€ ERDF funds
Conditional co-stimulation through 4-1BB exploiting Crosspriming in cancer CONDICOS CPP2022-009762 STATE INVESTIGATION AGENCY University of Navarra 2022 AEI PARTNERSHIP PUBLIC PRIVATE 18-12-2023 184.763,00€ MRR Funds
essay Phase I clinical trial of a new antifibrinolytic agent, compound CM-352, with an efficient synthesis route, aimed at the control of disabling and lethal bleeding. CPP2022-009643 STATE INVESTIGATION AGENCY University of Navarra 2022 AEI PARTNERSHIP PUBLIC PRIVATE 18-12-2023 1.161.431,98€ MRR Funds
development of a new tool for the prediction of premature mortality based on lifestyle, cognitive function and molecular biomarkers of aging. GN19/2023 GOVERNMENT OF NAVARRA. DEPARTMENT OF HEALTH high school of research Sanitaria de Navarra - IdiSNA 2023 GN Projects of research in health 18-12-2023 77.510,00€ -
Human bioengineering for the detection and analysis of cardiovascular toxicity secondary to anti-oncology therapies. Sex factor analysis. GN32/2023 GOVERNMENT OF NAVARRA. DEPARTMENT OF HEALTH high school of research Sanitaria de Navarra - IdiSNA 2023 GN Projects of research in health 18-12-2023 79.925,00€ -
Elikia study. Sustainable screening for cervical cancer: HPV detection by pooling of vaginal samples obtained by autotoma and co-diagnosis of other sexually transmitted infections. 32-2023 GOVERNMENT OF NAVARRA. DEPARTMENT OF HEALTH high school of research Sanitaria de Navarra - IdiSNA 2023 GN Projects of research in health 18-12-2023 79.154,07€ -

Aplicaciones anidadas

portaldetransparencia-subvenciones-feder


portaldetransparencia-subvenciones-fse


portaldetransparencia-subvenciones-aei


Aplicaciones anidadas

portaldetransparencia-subvenciones-fecyt


​​​​​​

portaldetransparencia-subvenciones-mciencia


Aplicaciones anidadas

logo rec tranfor


 

portaldetransparencia-subvenciones-gnavarra


portaldetransparencia-subvenciones-isciii